1cP-AL-LAD
| 1cP-AL-LAD | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
1cP-AL-LAD is a synthetic psychedelic compound that belongs to the lysergamide class. It is structurally related to LSD and is known for its psychoactive effects. 1cP-AL-LAD is a derivative of AL-LAD, with a cyclopropylcarbonyl group attached to the nitrogen of the indole ring.
Chemical Structure[edit]
1cP-AL-LAD is a lysergamide, which means it is a derivative of lysergic acid. The chemical structure of 1cP-AL-LAD includes a cyclopropylcarbonyl group, which is a distinguishing feature from other lysergamides such as LSD and AL-LAD. This modification is believed to affect the compound's pharmacokinetics and pharmacodynamics.
Pharmacology[edit]
1cP-AL-LAD acts primarily as a partial agonist at the 5-HT2A receptor, which is thought to be responsible for its psychedelic effects. Like other psychedelics, it may also interact with other serotonin receptors, contributing to its overall psychoactive profile. The exact mechanism of action and the full spectrum of its effects are still under investigation.
Effects[edit]
The effects of 1cP-AL-LAD are similar to those of other psychedelics, such as LSD and psilocybin. Users report altered perceptions, visual hallucinations, and changes in thought processes. The onset of effects typically occurs within 30 to 90 minutes after ingestion, with the experience lasting between 6 to 10 hours.
Legal Status[edit]
The legal status of 1cP-AL-LAD varies by country. In some jurisdictions, it may be considered a controlled substance due to its structural similarity to other illegal psychedelics. In others, it may be legal or exist in a legal gray area. Users should be aware of the laws in their specific location before obtaining or using 1cP-AL-LAD.
Safety and Risks[edit]
As with other psychedelics, the use of 1cP-AL-LAD carries potential risks, including psychological distress, anxiety, and the possibility of triggering latent mental health disorders. It is important for users to approach its use with caution, ideally in a safe and controlled environment.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
